A Study Comparing Atezolizumab (Anti PD-L1 Antibody) In Combination With Adjuvant Anthracycline/Taxane-Based Chemotherapy Versus Chemotherapy Alone In Patients With Operable Triple-Negative Breast Cancer
~14 mi.
(Badalona,
Spain,
+383 more cities)
Hospital Universitari Germans Trias i Pujol; Servicio de Oncologia
Perioperative Pembrolizumab (MK-3475) Plus Cystectomy or Perioperative Pembrolizumab Plus Enfortumab Vedotin Plus Cystectomy Versus Cystectomy Alone in Cisplatin-ineligible Participants With Muscle-invasive Bladder Cancer (MK-3475-905/KEYNOTE-905/EV-303)
~14 mi.
(Badalona,
Spain,
+163 more cities)
Hosp. Gral. Universitari Germans Trias i Pujol ( Site 0675)
A Study Evaluating the Efficacy and Safety of Adjuvant Atezolizumab or Placebo and Trastuzumab Emtansine for Participants With HER2-Positive Breast Cancer at High Risk of Recurrence Following Preoperative Therapy
~14 mi.
(Badalona,
Spain,
+260 more cities)
Hospital Universitari Germans Trias i Pujol; Servicio de Oncologia
Study of Pembrolizumab Given Prior to Surgery and in Combination With Radiotherapy Given Post-surgery for Advanced Head and Neck Squamous Cell Carcinoma (MK-3475-689)
~14 mi.
(Badalona,
Spain,
+150 more cities)
Hospital Germans Trias i Pujol. ICO de Badalona ( Site 1204)
A Phase 3 Efficacy, Safety and Tolerability Study of Zolbetuximab (Experimental Drug) Plus mFOLFOX6 Chemotherapy Compared to Placebo Plus mFOLFOX6 as Treatment for Gastric and Gastroesophageal Junction (GEJ) Cancer
Study Of Venetoclax Tablet With Intravenous or Subcutaneous Azacitidine to Assess Change in Disease Activity In Adult Participants With Newly Diagnosed Higher-Risk Myelodysplastic Syndrome
~14 mi.
(Badalona,
Spain,
+201 more cities)
Hospital Universitario Germans Trias i Pujol /ID# 221274